| Not Yet Recruiting | A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subc Relapsing-remitting Multiple Sclerosis | Phase 2 | 2026-08-01 |
| Not Yet Recruiting | A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance T Moderately to Severely Active Crohns Disease | Phase 3 | 2026-05-29 |
| Not Yet Recruiting | A COPD Data Registry for Participants With Frequent Exacerbations COPD | — | 2026-05-18 |
| Recruiting | A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With He Hemophilia A | Phase 3 | 2026-05-09 |
| Recruiting | A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Neuromyelitis Optica Spectrum Disorder, NMOSD | Phase 3 | 2026-04-30 |
| Recruiting | A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Plac Breast Cancer | Phase 2 | 2026-04-30 |
| Not Yet Recruiting | RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or HER2-positive Breast Cancer | Phase 2 / Phase 3 | 2026-04-30 |
| Recruiting | A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophili Hemophilia A | Phase 3 | 2026-04-30 |
| Recruiting | A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) Metastatic Colorectal Cancer | Phase 1 | 2026-04-21 |
| Not Yet Recruiting | A Study of Risdiplam in Participants With Type I and Type II Spinal Muscle Atrophy (SMA) Spinal Muscle Atrophy | — | 2026-04-15 |
| Recruiting | A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moder Moderately to Severely Active Ulcerative Colitis | Phase 3 | 2026-04-15 |
| Recruiting | A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Hear Stable Coronary Artery Disease, Healthy Volunteers | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A Hemophilia A | Phase 1 / Phase 2 | 2026-03-31 |
| Recruiting | A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants Wit Healthy Volunteers, Overweight or Obesity | Phase 1 | 2026-03-30 |
| Recruiting | A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Di Obesity or Overweight, Type 2 Diabetes Mellitus | Phase 3 | 2026-03-23 |
| Recruiting | A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight Without Type Obesity or Overweight | Phase 3 | 2026-03-16 |
| Withdrawn | A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS) Antiphospholipid Syndrome | Phase 2 | 2026-03-16 |
| Recruiting | A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-Resistant Prostate Cancer | Phase 2 | 2026-03-11 |
| Recruiting | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therap Progressive Multiple Sclerosis | Phase 2 | 2026-03-10 |
| Recruiting | A Study to Assess Treatment Patterns and Treatment Adherence in Early HER2-positive Breast Cancer Participants Early-stage HER2+ Breast Cancer | — | 2026-02-23 |
| Recruiting | To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer Breast Cancer | Phase 2 | 2026-02-18 |
| Recruiting | A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults a Traumatic Brain Injury | — | 2026-02-09 |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab an Colorectal Cancer | Phase 2 | 2026-02-01 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Partic Alzheimer's Disease | Phase 1 | 2026-01-27 |
| Recruiting | A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3C Locally Advanced Breast Cancer, Metastatic Breast Cancer | — | 2026-01-21 |
| Recruiting | A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis | Phase 2 | 2026-01-08 |
| Recruiting | A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Healthy Volunteers | Phase 1 | 2025-12-22 |
| Recruiting | A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arth Rheumatoid Arthritis | Phase 2 | 2025-12-05 |
| Recruiting | A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD Neovascular Age-related Macular Degeneration | Phase 3 | 2025-11-27 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | Phase 3 | 2025-11-24 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Huntington's Disease | Phase 1 | 2025-11-19 |
| Recruiting | A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Mul Multiple Sclerosis | Phase 2 | 2025-11-13 |
| Recruiting | A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Alzheimers Disease | Phase 3 | 2025-11-12 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer | Phase 3 | 2025-10-24 |
| Recruiting | A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Relapsing Multiple Sclerosis | Phase 2 | 2025-10-06 |
| Active Not Recruiting | A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus, Obesity, Overweight | Phase 1 | 2025-09-30 |
| Recruiting | An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma Diffuse Large B-Cell Lymphoma | — | 2025-09-29 |
| Recruiting | A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease Alzheimers Disease | Phase 3 | 2025-09-17 |
| Recruiting | A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer Breast Cancer | Phase 2 | 2025-09-09 |
| Active Not Recruiting | A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 2 | 2025-08-19 |
| Active Not Recruiting | A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least Obesity or Overweight | Phase 2 | 2025-07-29 |
| Recruiting | A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants T Lung Cancer, Hepatocellular Carcinoma | — | 2025-07-17 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity Geographic Atrophy, Age-related Macular Degeneration | Phase 1 | 2025-07-16 |
| Recruiting | A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Dry Eye Disease | Phase 4 | 2025-07-09 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Ocrelizumab in Participant Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 4 | 2025-07-04 |
| Recruiting | Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies Alzheimers Disease | Phase 3 | 2025-07-02 |
| Recruiting | A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease Von Willebrand Disease, Type 3 | Phase 3 | 2025-06-27 |
| Withdrawn | A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BC Non-muscle Invasive Bladder Cancer | Phase 1 | 2025-06-15 |
| Recruiting | A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastat Overweight, Obesity | Phase 1 | 2025-06-04 |
| Recruiting | A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relap Multiple Myeloma | Phase 1 | 2025-05-13 |
| Recruiting | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants Wit Moderately to Severely Active Crohns Disease | Phase 3 | 2025-05-12 |
| Active Not Recruiting | A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 Obesity, Overweight, Overweight With One Weight Related Comorbidity | Phase 2 | 2025-05-05 |
| Recruiting | Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adj Carcinoma, Non-Small-Cell Lung | — | 2025-04-30 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO767 Neoplasms | Phase 1 | 2025-04-30 |
| Recruiting | An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Tre Von Willebrand Disease, Type 3 | — | 2025-04-29 |
| Recruiting | A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Rel Lymphoma | Phase 1 | 2025-04-28 |
| Recruiting | Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in R Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | N/A | 2025-04-14 |
| Active Not Recruiting | A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH L MASH | Phase 1 | 2025-04-14 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4 Breast Cancer | Phase 3 | 2025-04-09 |
| Active Not Recruiting | A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) Duchenne Muscular Dystrophy | Phase 2 | 2025-04-04 |
| Recruiting | A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe At Atopic Dermatitis | Phase 2 | 2025-04-01 |
| Recruiting | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Moderately to Severely Active Crohns Disease | Phase 3 | 2025-03-17 |
| Active Not Recruiting | A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Re Neovascular Age-related Macular Degeneration (nAMD) | Phase 4 | 2025-03-14 |
| Recruiting | A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination Wi B-Cell Non-Hodgkins Lymphoma | Phase 2 | 2025-03-05 |
| Recruiting | A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease Huntington Disease | Phase 1 / Phase 2 | 2025-02-21 |
| Completed | A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compoun Healthy Participants | Phase 1 | 2025-02-13 |
| Recruiting | A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study) Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | — | 2025-02-05 |
| Completed | A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2025-01-08 |
| Completed | A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participan Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | — | 2024-12-31 |
| Completed | Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Bacterial Vaginosis, Candida Vaginitis | — | 2024-12-30 |
| Recruiting | An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocre Multiple Sclerosis | Phase 3 | 2024-12-13 |
| Recruiting | A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Pa Moderately to Severely Active Ulcerative Colitis | Phase 3 | 2024-12-11 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Par Muscle-invasive Urothelial Carcinoma | Phase 2 | 2024-12-09 |
| Withdrawn | A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Solid Tumors | Phase 2 | 2024-11-30 |
| Active Not Recruiting | A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cel Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-11-18 |
| Completed | Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Particip Influenza | Phase 3 | 2024-10-27 |
| Recruiting | Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Relapsing Remitting Multiple Sclerosis | — | 2024-10-21 |
| Recruiting | A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Particip Multiple Sclerosis | — | 2024-09-26 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Pre Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer | Phase 3 | 2024-09-23 |
| Active Not Recruiting | A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenanc Moderately to Severely Active Ulcerative Colitis | Phase 3 | 2024-09-17 |
| Active Not Recruiting | A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Cancer-Neoplasms | Phase 1 | 2024-09-16 |
| Recruiting | Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers Huntington Disease | — | 2024-09-02 |
| Recruiting | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Mu Muscular Atrophy, Spinal | Phase 4 | 2024-08-14 |
| Completed | A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increas Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection | N/A | 2024-07-29 |
| Completed | A Study of Participants With Initially Unresectable Hepatocellular Carcinoma That is Treated With Atezolizumab Unresectable Hepatocellular Carcinoma | — | 2024-07-19 |
| Recruiting | A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) Neovascular Age-related Macular Degeneration, nAMD | Phase 3 | 2024-06-17 |
| Recruiting | A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatri Muscular Atrophy, Spinal | Phase 4 | 2024-05-30 |
| Recruiting | Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Diabetic Macular Edema, Neovascular Age-related Macular Degeneration, Retinal Vein Occlusion | — | 2024-05-09 |
| Active Not Recruiting | A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodro Alzheimer's Disease | Phase 2 | 2024-05-02 |
| Recruiting | A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy Muscular Atrophy, Spinal | Phase 2 | 2024-04-26 |
| Recruiting | A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies Breast Cancer | Phase 4 | 2024-04-02 |
| Completed | A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Complete Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2024-03-21 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Seconda Choroidal Neovascularization Secondary to Pathologic Myopia | Phase 3 | 2024-03-06 |
| Completed | A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants | Phase 1 | 2024-02-14 |
| Withdrawn | A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizu Neovascular Age-Related Macular Degeneration | Phase 3 | 2023-12-29 |
| Recruiting | A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO750 Systemic Lupus Erythematosus | Phase 1 | 2023-12-18 |
| Completed | A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in P Relapsed or Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2023-12-12 |
| Recruiting | A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab, and Inavolisib Plus Pembrolizumab in PIK3CA-Mutated Cancers | Phase 1 | 2023-12-11 |
| Recruiting | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), i Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer | Phase 3 | 2023-12-11 |
| Completed | A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgical Carcinoma, Hepatocellular | Phase 1 / Phase 2 | 2023-12-05 |
| Withdrawn | A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MT Medullary Thyroid Cancer | Phase 3 | 2023-11-30 |
| Active Not Recruiting | A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Un Duchenne Muscular Dystrophy | Phase 2 | 2023-11-29 |
| Recruiting | A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Tran Influenza | Phase 3 | 2023-11-22 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participan Thyroid Eye Disease | Phase 3 | 2023-11-15 |
| Recruiting | A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2023-11-14 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participan Thyroid Eye Disease, TED | Phase 3 | 2023-10-26 |
| Recruiting | A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refra Lymphoma | Phase 3 | 2023-10-22 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Pe Hemophilia A | Phase 1 / Phase 2 | 2023-09-21 |
| Active Not Recruiting | An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, a Large B-Cell Lymphoma | Phase 3 | 2023-09-18 |
| Withdrawn | A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple Sclerosis Multiple Sclerosis | Phase 4 | 2023-09-15 |
| Active Not Recruiting | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated L Hepatocellular Carcinoma | Phase 3 | 2023-09-14 |
| Completed | A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer Metastatic Lung Cancer, Metastatic Gastrointestinal Cancer | N/A | 2023-09-14 |
| Completed | A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Partic Breast Cancer | — | 2023-09-13 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combina Metastatic Breast Cancer | Phase 3 | 2023-09-08 |
| Active Not Recruiting | A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Ch Diffuse Large B-Cell Lymphoma | — | 2023-08-25 |
| Active Not Recruiting | A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery Carcinoma, Non-Small-Cell Lung | — | 2023-08-11 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobu Primary IgA Nephropathy | Phase 3 | 2023-08-08 |
| Completed | A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in C Angelman Syndrome | Phase 2 | 2023-07-27 |
| Active Not Recruiting | Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease Crohns Disease | Phase 2 | 2023-07-24 |
| Active Not Recruiting | A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Prev Breast Cancer | Phase 2 | 2023-07-18 |
| Recruiting | A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Dis Chronic Obstructive Pulmonary Disease | Phase 3 | 2023-06-28 |
| Active Not Recruiting | A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer Endometrial Cancer | Phase 2 | 2023-06-27 |
| Recruiting | A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2023-06-20 |
| Terminated | Study of RO7515629 in Participants With HLA-G Positive Solid Tumors Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma | Phase 1 | 2023-06-15 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvest Breast Cancer | Phase 3 | 2023-06-07 |
| Recruiting | A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Stud Cancer | Phase 3 | 2023-06-01 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tira PD-L1-selected Solid Tumors | Phase 2 | 2023-05-04 |
| Terminated | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Pa Chronic Hepatitis B | Phase 1 | 2023-04-28 |
| Active Not Recruiting | A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advan Renal Cell Carcinoma | Phase 2 | 2023-04-21 |
| Active Not Recruiting | A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) i Urothelial Cancer | Phase 2 | 2023-04-13 |
| Completed | A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Sq Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | 2023-04-12 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Id Childhood Idiopathic Nephrotic Syndrome | Phase 3 | 2023-03-29 |
| Completed | Vamikibart in Participants With Uveitic Macular Edema Uveitic Macular Edema | Phase 3 | 2023-03-23 |
| Active Not Recruiting | A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in P Non-small Cell Lung Cancer | Phase 2 | 2023-03-15 |
| Terminated | Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinic Cancer | Phase 2 / Phase 3 | 2023-02-27 |
| Active Not Recruiting | A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy Facioscapulohumeral Muscular Dystrophy (FSHD) | Phase 2 | 2023-02-07 |
| Active Not Recruiting | GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo i Huntington Disease | Phase 2 | 2023-02-03 |
| Completed | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activ Small Cell Lung Cancer, Neuroendocrine Carcinoma | Phase 1 | 2023-01-23 |
| Completed | A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema Uveitic Macular Edema | Phase 3 | 2023-01-09 |
| Recruiting | A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2022-12-29 |
| Terminated | A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Sy Dup15q Syndrome | Phase 2 | 2022-12-16 |
| Completed | A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infecti Bacterial Infections | Phase 1 | 2022-12-03 |
| Withdrawn | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants Guillain-Barré Syndrome | Phase 3 | 2022-11-30 |
| Active Not Recruiting | A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion | — | 2022-11-21 |
| Recruiting | A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Pa Mature B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2022-11-16 |
| Completed | A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Diffuse Large B-Cell Lymphoma (DLBCL) | Phase 1 | 2022-11-04 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advan Non-Small Cell Lung Cancer | Phase 3 | 2022-11-01 |
| Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination Wi Non-Hodgkin Lymphoma | Phase 1 | 2022-10-26 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Par Multiple Myeloma | Phase 1 / Phase 2 | 2022-10-17 |
| Completed | A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate th Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 3 | 2022-10-17 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis | Phase 3 | 2022-09-27 |
| Completed | A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Partici Parkinson Disease | Phase 1 | 2022-09-22 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participan Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) | Phase 3 | 2022-08-30 |
| Completed | A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Me Melanoma | Phase 2 | 2022-08-15 |
| Terminated | A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention Neuromyelitis Optica Spectrum Disorder, NMOSD | Phase 4 | 2022-08-02 |
| Completed | Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD) Stress Disorders, Post-Traumatic | Phase 2 | 2022-08-02 |
| Completed | Screening Study for Participants With Malignant Tumors Solid Tumors | Phase 2 | 2022-07-22 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzuma Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2022-07-18 |
| Completed | A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Tra Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer | Phase 3 | 2022-07-05 |
| Withdrawn | The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan Autism Spectrum Disorder | Phase 1 | 2022-06-26 |
| Withdrawn | Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High R Acute Ischemic Stroke | Phase 2 | 2022-06-22 |
| Active Not Recruiting | A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moder Severe Hemophilia A, Moderate Hemophilia A | Phase 4 | 2022-06-20 |
| Active Not Recruiting | A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Sq Non-Small Cell Lung Cancer | Phase 3 | 2022-06-14 |
| Completed | A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19 COVID-19 | Phase 1 | 2022-06-10 |
| Active Not Recruiting | A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Parti Spinal Muscular Atrophy (SMA) | Phase 2 / Phase 3 | 2022-06-02 |
| Completed | A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combin Healthy Male Subjects | Phase 1 | 2022-05-30 |
| Active Not Recruiting | A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescen Relapsing-Remitting Multiple Sclerosis | Phase 3 | 2022-05-19 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Clas Lupus Nephritis | Phase 2 | 2022-05-12 |
| Terminated | An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Com Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 / Phase 2 | 2022-05-10 |
| Completed | A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pha Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 3 | 2022-05-03 |
| Active Not Recruiting | A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclero Multiple Sclerosis | Phase 3 | 2022-05-03 |
| Active Not Recruiting | A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Ri Non-Hodgkin Lymphoma | Phase 3 | 2022-04-25 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Sta Alzheimers Disease | Phase 3 | 2022-04-19 |
| Completed | A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | 2022-04-13 |
| Completed | A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Gliob Glioblastoma | Phase 1 | 2022-04-05 |
| Completed | A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Non-small Cell Lung Cancer | Phase 2 | 2022-04-04 |
| Completed | A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Managemen Sickle Cell Disease | Phase 1 | 2022-03-26 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophospham Lymphoma | Phase 2 | 2022-03-22 |
| Active Not Recruiting | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants Wi Rectal Neoplasms, Rectal Cancer | Phase 2 | 2022-03-18 |
| Completed | A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treat Sickle Cell Disease | Phase 2 | 2022-03-09 |
| Recruiting | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosun Chronic Lymphocytic Leukemia | Phase 1 | 2022-03-07 |
| Active Not Recruiting | A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS) Relapsing Multiple Sclerosis | Phase 2 | 2022-03-01 |
| Terminated | An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastr Gastric and Gastroesophageal Junction Carcinoma | Phase 1 / Phase 2 | 2022-03-01 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Lymphoma, Non-Hodgkin | Phase 1 | 2022-02-18 |
| Completed | A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morph Melanoma | Phase 1 / Phase 2 | 2022-02-02 |
| Terminated | A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants Solid Tumors | Phase 1 | 2022-01-25 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Adminis Systemic Lupus Erythematosus | Phase 1 | 2022-01-11 |
| Completed | A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema Diabetic Macular Edema | Phase 2 | 2021-12-31 |
| Completed | A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema Diabetic Macular Edema | Phase 2 | 2021-12-17 |
| Active Not Recruiting | An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsore Neoplasms | Phase 3 | 2021-12-01 |
| Terminated | A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer Carcinoma, Small Cell Lung | Phase 2 | 2021-12-01 |
| Active Not Recruiting | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atez Small-Cell Lung Cancer | Phase 3 | 2021-11-18 |
| Active Not Recruiting | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Part Atypical Hemolytic Uremic Syndrome | Phase 3 | 2021-11-17 |
| Completed | A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome Acute Coronary Syndrome, Myocardial Infarction | — | 2021-11-15 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Relapsed or Refractory Follicular Lymphoma | Phase 3 | 2021-10-27 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 3 | 2021-10-26 |
| Active Not Recruiting | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adol Atypical Hemolytic Uremic Syndrome | Phase 3 | 2021-10-22 |
| Recruiting | A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Metastatic Colorectal Cancer | Phase 1 | 2021-10-22 |
| Terminated | A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis | Phase 3 | 2021-10-19 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurr Ovarian Cancer | Phase 2 | 2021-10-07 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Meta Carcinoma, Non-Small-Cell Lung | Phase 3 | 2021-09-30 |
| Completed | A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab Multiple Sclerosis, Clinically Isolated Syndrome | Phase 4 | 2021-09-16 |
| Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK ALK Fusion-positive Solid or CNS Tumors | Phase 1 / Phase 2 | 2021-09-14 |
| Terminated | A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Parti Idiopathic Pulmonary Fibrosis | Phase 3 | 2021-08-30 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuva Early Breast Cancer | Phase 3 | 2021-08-27 |
| Completed | A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-08-26 |
| Recruiting | A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO Multiple Sclerosis | Phase 1 | 2021-08-11 |
| Terminated | A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Stomach Neoplasms, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2021-08-06 |
| Completed | Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 Metastatic Colorectal Cancer | Phase 1 | 2021-07-14 |
| Active Not Recruiting | A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System Neovascular Age-related Macular Degeneration (nAMD) | Phase 3 | 2021-07-14 |
| Terminated | A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax in Combination With Polatuzumab Ved Lymphoma, Large B-Cell, Diffuse | Phase 1 | 2021-07-02 |
| Withdrawn | A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezoliz Carcinoma, Non-Small Cell Lung | Phase 2 | 2021-07-01 |
| Completed | A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Ad Advanced or Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-06-25 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy Primary Membranous Nephropathy | Phase 3 | 2021-06-25 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Canc Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer | Phase 1 / Phase 2 | 2021-06-22 |
| Terminated | A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a COVID-19, Long COVID | — | 2021-06-15 |
| Terminated | A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants W Metastatic Breast Cancer | Phase 3 | 2021-06-07 |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic Neoplasms, Colorectal Neoplasms, Melanoma | Phase 2 | 2021-05-24 |
| Completed | A Study to Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combi Solid Tumors | Phase 1 | 2021-05-18 |
| Active Not Recruiting | An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NS NSCLC | — | 2021-05-10 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Parkinsons Disease | Phase 2 | 2021-05-05 |
| Terminated | A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable fo Carcinoma, Hepatocellular | Phase 3 | 2021-05-04 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for P Breast Cancer | Phase 3 | 2021-05-04 |
| Active Not Recruiting | A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Blad Muscle-invasive Bladder Cancer | Phase 3 | 2021-05-03 |
| Completed | A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses O Angelman Syndrome | Phase 1 | 2021-04-29 |
| Terminated | Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With COVID-19 | Phase 3 | 2021-04-28 |
| Active Not Recruiting | A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Ca Unresectable Hepatocellular Carcinoma | Phase 3 | 2021-04-26 |
| Terminated | A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | 2021-04-23 |
| Completed | A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Re Neovascular Age-related Macular Degeneration | Phase 3 | 2021-04-19 |
| Terminated | Effect of RO7049665 on the Time to Relapse Following Steroid Tapering in Participants With Autoimmune Hepatiti Autoimmune Hepatitis, Autoimmune Chronic Hepatitis | Phase 2 | 2021-04-19 |
| Withdrawn | A Study of the Efficacy and Safety of RO7198457 in Combination With Atezolizumab Versus Atezolizumab Alone Fol Non-small Cell Lung Cancer (NSCLC) | Phase 2 | 2021-03-31 |
| Completed | Mass Balance and Absolute Bioavailability Study of RO7049389 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2021-03-31 |
| Completed | A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Parti Autism Spectrum Disorder (ASD) | Phase 2 | 2021-03-31 |
| Active Not Recruiting | Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sc Relapsing Multiple Sclerosis | Phase 3 | 2021-03-24 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participant Idiopathic Pulmonary Fibrosis | Phase 3 | 2021-03-19 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Relapsing Multiple Sclerosis | Phase 3 | 2021-03-17 |
| Active Not Recruiting | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants W Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2021-03-17 |
| Active Not Recruiting | Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, an Alzheimers Disease | Phase 1 / Phase 2 | 2021-03-15 |
| Active Not Recruiting | A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2021-03-12 |
| Active Not Recruiting | A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocel Hepatocellular Carcinoma | Phase 3 | 2021-03-12 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branc Macular Edema, Branch Retinal Vein Occlusion | Phase 3 | 2021-03-02 |
| Completed | A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2021-03-02 |
| Completed | A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Neuromyelitis Optica Spectrum Disorder | Phase 3 | 2021-03-02 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Centr Macular Edema, Central Retinal Vein Occlusion, Hemiretinal Vein Occlusion | Phase 3 | 2021-03-02 |
| Completed | A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, Lymphoma, Large B-Cell, Diffuse | Phase 2 | 2021-02-24 |
| Active Not Recruiting | A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combinat Diffuse Large B-cell Lymphoma | Phase 3 | 2021-02-23 |
| Completed | A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients Biliary Tract Cancer | Phase 2 | 2021-02-23 |
| Completed | A Study To Monitor Lung Cancer Patients Activity And Assess Performance Status Through A Wearable Device. Non-Small Cell Lung Cancer (NSCLC) | — | 2021-02-18 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Severe Hemophilia A | Phase 3 | 2021-02-04 |
| Completed | Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19 COVID-19 | Phase 2 | 2021-02-03 |
| Completed | Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants Muscular Atrophy, Spinal | Phase 1 | 2021-02-01 |
| Terminated | A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Partici Alzheimer Disease | Phase 3 | 2021-01-26 |
| Active Not Recruiting | Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study Solid Tumors | Phase 2 | 2021-01-18 |
| Completed | A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Pa Lymphoma | Phase 1 | 2021-01-08 |
| Terminated | A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants Solid Tumors | Phase 1 | 2021-01-04 |
| Active Not Recruiting | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreate Small Cell Lung Carcinoma | Phase 3 | 2020-12-21 |
| Completed | Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Pa Carcinoma, Small Cell Lung | Phase 2 | 2020-12-16 |
| Completed | A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembr Non-small Cell Lung Cancer (NSCLC) | Phase 2 / Phase 3 | 2020-12-15 |
| Completed | A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections o Geographic Atrophy | Phase 1 | 2020-12-08 |
| Completed | A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous A Healthy Volunteers | Phase 1 | 2020-12-07 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W Multiple Sclerosis | Phase 3 | 2020-12-03 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monot Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer | Phase 2 | 2020-11-27 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults W Multiple Sclerosis | Phase 3 | 2020-11-26 |
| Completed | A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Di Diabetic Macular Edema | Phase 2 | 2020-11-25 |
| Terminated | A Study to Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Particip Alzheimer Disease | Phase 2 | 2020-11-18 |
| Completed | A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Rela Multiple Myeloma | Phase 1 | 2020-11-11 |
| Completed | A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynam Acute Myeloid Leukemia | Phase 1 | 2020-11-04 |
| Completed | A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Met Solid Tumors | Phase 1 | 2020-11-03 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients Advanced Liver Cancers | Phase 1 / Phase 2 | 2020-11-01 |
| Completed | A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel Esophageal Cancer | Phase 3 | 2020-10-30 |
| Active Not Recruiting | Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration Macular Degeneration | Phase 1 / Phase 2 | 2020-10-28 |
| Completed | A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positiv Cutaneous Melanoma, Uveal Melanoma, Mucosal Melanoma | Phase 1 | 2020-10-28 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants Wi Multiple Sclerosis, Primary Progressive | Phase 3 | 2020-10-26 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole C Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2020-10-09 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Noc Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2020-10-08 |
| Completed | Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Carcinoma, Non-Small-Cell Lung | Phase 3 | 2020-10-01 |
| Active Not Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | 2020-09-30 |
| Completed | A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chem Triple-Negative Breast Cancer | Phase 1 | 2020-09-28 |
| Active Not Recruiting | A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Esophageal Squamous Cell Carcinoma | Phase 3 | 2020-09-28 |
| Terminated | A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients Breast Cancer | Phase 1 / Phase 2 | 2020-09-23 |
| Terminated | A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Small Cell Lung Cancer | Phase 1 | 2020-09-22 |
| Completed | A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Carcinoma, Non-Small-Cell Lung | Phase 2 | 2020-09-09 |
| Completed | A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerb Schizophrenia, Schizoaffective Disorder | Phase 2 | 2020-09-08 |
| Completed | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Early Breast Cancer | Phase 2 | 2020-09-04 |
| Active Not Recruiting | A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Facto Advanced Solid Tumors, HER2-positive Breast Cancer | Phase 1 / Phase 2 | 2020-09-03 |
| Recruiting | A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test Solid Tumours | — | 2020-08-27 |
| Completed | A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Pati Carcinoma, Hepatocellular | Phase 3 | 2020-08-25 |
| Completed | A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unrese Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2020-08-24 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 Angelman Syndrome | Phase 1 | 2020-08-19 |
| Active Not Recruiting | A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Follicular Lymphoma | Phase 1 / Phase 2 | 2020-08-12 |
| Completed | A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Mac Diabetic Retinopathy | Phase 3 | 2020-08-10 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis | Phase 3 | 2020-08-10 |
| Completed | A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Carcinoma, Thymic | Phase 2 | 2020-08-07 |
| Completed | A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular E Diabetic Macular Edema | Phase 3 | 2020-08-05 |
| Terminated | A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With A Carcinoma, Renal Cell | Phase 3 | 2020-07-28 |
| Terminated | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer RET-fusion Non Small Cell Lung Cancer, Lung Neoplasm, Carcinoma, Non-Small-Cell Lung | Phase 3 | 2020-07-24 |
| Completed | A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonis Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer | Phase 1 | 2020-07-16 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO69539 Autistic Disorder, Autism Spectrum Disorder, Child Development Disorders, Pervasive | Phase 1 | 2020-07-15 |
| Terminated | A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination With Bendamustine and Rituxi Diffuse, Large B-Cell, Lymphoma | Phase 3 | 2020-07-10 |
| Terminated | A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab A Castration-Resistant Prostatic Cancer | Phase 1 | 2020-07-09 |
| Completed | A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hep Hepatitis B, Chronic | Phase 2 | 2020-07-05 |
| Completed | A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or R Cervical Cancer | Phase 2 | 2020-06-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Place COVID-19 Pneumonia | Phase 3 | 2020-06-16 |
| Completed | A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 W Diabetic Retinopathy | Phase 2 | 2020-06-05 |
| Completed | A Study Evaluating the Safety and Efficacy of Glofitamab or Mosunetuzumab in Combination With Gemcitabine Plus B-cell Lymphoma | Phase 1 | 2020-06-04 |
| Completed | A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludara Chronic Lymphocytic Leukemia (CLL) | Phase 3 | 2020-05-28 |
| Terminated | A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants Wi Alzheimer Disease | Phase 3 | 2020-05-22 |
| Completed | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia COVID-19 Pneumonia | Phase 2 | 2020-05-05 |
| Completed | A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Solid Tumors | Phase 1 | 2020-05-04 |
| Completed | A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy Carcinoma, Non-Small-Cell Lung | Phase 3 | 2020-04-09 |
| Completed | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia COVID-19 Pneumonia | Phase 3 | 2020-04-03 |
| Completed | A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab Non-Small Cell Lung Cancer | Phase 3 | 2020-03-04 |
| Completed | An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, i Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Haemophilia A | — | 2020-02-24 |
| Active Not Recruiting | A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer | — | 2020-02-21 |
| Completed | A Study to Investigate the Effect of Impaired Hepatic Function on the Pharmacokinetics of Entrectinib in Volun Hepatic Insufficiency | Phase 1 | 2020-02-11 |
| Completed | A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor, Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor, Hemophilia A | Phase 3 | 2020-02-10 |
| Completed | A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine Diffuse Large B-Cell Lymphoma | Phase 3 | 2020-02-07 |
| Completed | A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the F HER2-positive Early Breast Cancer | Phase 3 | 2020-02-05 |
| Completed | RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors Solid Tumor, Unspecified, Adult | Phase 1 | 2020-02-04 |
| Completed | A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Small Cell Lung Cancer | Phase 3 | 2020-02-04 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib Breast Cancer | Phase 2 / Phase 3 | 2020-01-29 |
| Terminated | A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combi Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma | Phase 1 / Phase 2 | 2020-01-27 |
| Active Not Recruiting | A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis Multiple Sclerosis | Phase 2 | 2020-01-09 |
| Active Not Recruiting | A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepat Carcinoma, Hepatocellular | Phase 3 | 2019-12-31 |
| Completed | A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Coliti Moderate to Severe Ulcerative Colitis | Phase 2 | 2019-12-19 |
| Terminated | A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Sp Autism Spectrum Disorder | Phase 1 | 2019-12-19 |
| Completed | A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD Triple-Negative Breast Cancer | Phase 3 | 2019-12-10 |
| Terminated | A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors Solid Tumors | Phase 1 | 2019-12-09 |
| Completed | A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Lo Triple-Negative Breast Cancer | Phase 3 | 2019-11-25 |
| Completed | Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Muco Melanoma | Phase 2 | 2019-11-25 |
| Terminated | A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hor Breast Cancer | Phase 1 | 2019-11-21 |
| Completed | A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan Autism Spectrum Disorder | Phase 1 | 2019-11-19 |
| Active Not Recruiting | Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumo Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2019-11-11 |
| Completed | Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A Influenza | Phase 3 | 2019-10-10 |
| Terminated | A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 t Acute Myeloid Leukemia | Phase 1 | 2019-10-08 |
| Recruiting | A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Diabetic Macular Edema | Phase 3 | 2019-09-30 |
| Completed | A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Huntingtons Disease | Phase 1 | 2019-09-02 |
| Completed | Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN) Follicular Lymphoma | — | 2019-09-02 |
| Active Not Recruiting | A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Co Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2019-08-13 |
| Completed | A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in P Small Cell Lung Carcinoma | Phase 3 | 2019-08-12 |
| Completed | A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administrati Multiple Sclerosis (MS) | Phase 1 | 2019-08-12 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Scleros Multiple Sclerosis, Primary Progressive | Phase 3 | 2019-08-12 |
| Active Not Recruiting | A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy Muscular Atrophy, Spinal | Phase 2 | 2019-08-07 |
| Completed | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Pa Giant Cell Arteritis | Phase 1 | 2019-08-05 |
| Completed | A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Alzheimers Disease | Phase 1 | 2019-08-03 |
| Completed | A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabe Diabetic Macular Edema, Uveitic Macular Edema | Phase 1 | 2019-07-22 |
| Completed | A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Adv Non-small Cell Lung Cancer | Phase 3 | 2019-07-03 |
| Completed | A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Partici Metastatic Melanoma | Phase 1 | 2019-06-24 |
| Completed | Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Partici Healthy Volunteer | N/A | 2019-06-19 |
| Completed | A Drug-drug Interaction Study With Risdiplam Multiple Dose and Midazolam in Healthy Participants Spinal Muscular Atrophy | Phase 1 | 2019-06-18 |
| Completed | A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With R Breast Cancer, Prostate Cancer, Ovarian Cancer | Phase 1 | 2019-06-12 |
| Completed | Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Place Alzheimer Disease | Phase 2 | 2019-06-10 |
| Completed | Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patien Urothelial Carcinoma, Bladder Cancer | Phase 1 / Phase 2 | 2019-06-01 |
| Completed | Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Diffuse Large B-cell Lymphoma | Phase 1 / Phase 2 | 2019-05-23 |
| Completed | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of Muscular Atrophy, Spinal | Phase 1 | 2019-05-16 |
| Terminated | Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants Wi Ulcerative Colitis | Phase 1 | 2019-05-13 |
| Terminated | A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Ate Colorectal Cancer | Phase 1 | 2019-05-07 |
| Completed | An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntingto Huntington Disease | Phase 3 | 2019-04-23 |
| Terminated | A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in P Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2019-03-25 |
| Completed | A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation an Healthy Volunteers | Phase 1 | 2019-03-12 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Wet Macular Degeneration | Phase 3 | 2019-03-11 |
| Completed | A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (B B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2019-03-08 |
| Active Not Recruiting | A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Cancer | Phase 3 | 2019-02-28 |
| Completed | An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma | Phase 4 | 2019-02-26 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Wet Macular Degeneration | Phase 3 | 2019-02-19 |
| Active Not Recruiting | A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer | — | 2019-02-07 |
| Completed | Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects Healthy Volunteers | Phase 1 | 2019-02-07 |
| Completed | Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Particip Influenza | Phase 3 | 2019-01-23 |
| Completed | A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants W Huntingtons Disease | Phase 3 | 2019-01-23 |
| Completed | A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorub Breast Cancer | Phase 3 | 2019-01-11 |
| Withdrawn | A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma | Phase 3 | 2019-01-11 |
| Completed | A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Dos Healthy Volunteers | Phase 1 | 2019-01-10 |
| Completed | A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Pa OVARIAN CANCER | Phase 1 | 2019-01-09 |
| Completed | Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase I Influenza | Phase 3 | 2019-01-08 |
| Completed | A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metas Non-Small Cell Lung Cancer | Phase 3 | 2018-12-27 |
| Completed | A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combi HER2-Positive Early Breast Cancer | Phase 2 | 2018-12-19 |
| Completed | A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Particip Healthy Volunteers | Phase 1 | 2018-12-17 |
| Terminated | A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunt Hepatitis B Virus Infection | Phase 1 | 2018-12-14 |
| Completed | A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma Wit Metastatic Melanoma | Phase 2 | 2018-12-13 |
| Completed | Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Huntington's Disease | Phase 1 | 2018-12-05 |
| Completed | An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cance Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms | Phase 4 | 2018-12-05 |
| Terminated | A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Schizophrenia, Schizoaffective Disorder | Phase 2 | 2018-12-04 |
| Completed | Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Particip Influenza | Phase 3 | 2018-11-20 |
| Completed | Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Scleros Multiple Sclerosis | — | 2018-11-12 |
| Completed | 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capac Schizophrenia | Phase 1 | 2018-11-07 |
| Completed | A Study to Investigate the Effect of RO7049389 on the Pharmacokinetics of Pitavastatin in Healthy Volunteers Healthy Volunteers | Phase 1 | 2018-11-07 |
| Completed | A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With A Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2018-10-15 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Ede Diabetic Macular Edema | Phase 3 | 2018-10-09 |
| Terminated | A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients Colorectal Cancer | Phase 1 / Phase 2 | 2018-09-27 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedot B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2018-09-25 |
| Recruiting | Extension Study for the Port Delivery System With Ranibizumab (Portal) Neovascular Age-Related Macular Degeneration | Phase 3 | 2018-09-20 |
| Completed | A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Inje Neovascular Age-Related Macular Degeneration | Phase 3 | 2018-09-12 |
| Terminated | A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Rec Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer | Phase 2 | 2018-09-06 |
| Completed | A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Ede Diabetic Macular Edema | Phase 3 | 2018-09-05 |
| Completed | A Double-Blind Single-Ascending Dose (SAD) and Multiple-Ascending Dose (MAD) Study to Investigate the Safety, Hepatitis B Virus | Phase 1 | 2018-08-24 |
| Terminated | Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) Alzheimer Disease | Phase 3 | 2018-08-22 |
| Active Not Recruiting | A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Carcinoma, Non-Small-Cell Lung | Phase 3 | 2018-08-16 |
| Completed | A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 3 | 2018-08-15 |
| Completed | A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With A Autism Spectrum Disorder | Phase 1 | 2018-08-13 |
| Terminated | A Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension Autism Spectrum Disorder | Phase 3 | 2018-08-08 |
| Completed | A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Acti Multiple Sclerosis | Phase 4 | 2018-08-06 |
| Completed | Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Ped Anemia, Renal Insufficiency, Chronic | Phase 2 | 2018-08-03 |
| Terminated | A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based C Triple Negative Breast Cancer | Phase 3 | 2018-08-02 |
| Completed | Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers Healthy Participants | Phase 1 | 2018-07-27 |
| Completed | A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteer Healthy Volunteers | Phase 1 | 2018-07-24 |
| Completed | This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Par Multiple Sclerosis | Phase 3 | 2018-07-12 |
| Completed | A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Vers Cancer of Unknown Primary Site | Phase 2 | 2018-07-10 |
| Completed | A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunte Healthy Volunteers | Phase 1 | 2018-07-10 |
| Terminated | A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors Solid Tumors | Phase 1 | 2018-07-04 |
| Completed | A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dos Early Breast Cancer | Phase 3 | 2018-06-14 |
| Completed | A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants Wit Breast Cancer | Phase 2 | 2018-06-12 |
| Terminated | Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) Alzheimer Disease | Phase 3 | 2018-06-06 |
| Completed | The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer A Non-Small Cell Lung Cancer (NSCLC) | — | 2018-05-30 |
| Active Not Recruiting | A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis Progressive Multiple Sclerosis (PMS) | Phase 3 | 2018-05-28 |
| Completed | Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System Diabetes Mellitus, Type 1 | N/A | 2018-05-17 |
| Completed | A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chin Healthy Participants | Phase 1 | 2018-05-15 |
| Completed | An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps Nasal Polyps, Chronic Rhinosinusitis | Phase 3 | 2018-05-09 |
| Active Not Recruiting | An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With R Non-Hodgkins Lymphoma | Phase 1 / Phase 2 | 2018-05-08 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers. Healthy Participants | Phase 1 | 2018-05-03 |
| Completed | Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A P Hemophilia A | Phase 3 | 2018-04-26 |
| Completed | A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA) Juvenile Idiopathic Arthritis | Phase 4 | 2018-04-26 |
| Completed | A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resect Non-Small-Cell Lung | Phase 3 | 2018-04-24 |
| Completed | Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 Autism Spectrum Disorder | Phase 1 | 2018-04-24 |
| Terminated | An Open-Label Crenezumab Study in Participants With Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2018-04-11 |
| Terminated | A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients W Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Phase 3 | 2018-04-03 |
| Recruiting | A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or L Metastatic Breast Cancer | Phase 1 / Phase 2 | 2018-03-30 |
| Terminated | A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients Wi Ulcerative Colitis, Crohn's Disease | Phase 1 | 2018-03-27 |
| Completed | A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Loc Carcinoma, Hepatocellular | Phase 3 | 2018-03-15 |
| Withdrawn | A Study of Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Ther Lymphoma, Non-Hodgkin | Phase 1 | 2018-03-14 |
| Completed | A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincri B-Cell Lymphoma, Non-Hodgkin Lymphoma | Phase 1 | 2018-03-13 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese Volunte Healthy Volunteers, Hemophilia A | Phase 1 | 2018-03-12 |
| Completed | Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously U Chronic Lymphocytic Leukemia, Follicular Lymphoma | — | 2018-03-09 |
| Completed | A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Impr Diabetes Mellitus | N/A | 2018-02-28 |
| Terminated | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Polycythemia Vera | Phase 2 | 2018-02-21 |
| Terminated | Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers | Phase 2 | 2018-02-19 |
| Completed | Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on Neoplasms | Phase 4 | 2018-02-16 |
| Terminated | Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors Advanced or Metastatic Solid Tumors | EARLY_Phase 1 | 2018-02-15 |
| Completed | A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Breast Cancer | Phase 1 | 2018-02-13 |
| Completed | A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentin Urothelial Carcinoma | — | 2018-02-09 |
| Completed | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurre Triple Negative Breast Neoplasms | Phase 3 | 2018-01-11 |
| Completed | A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Al Breast Cancer | Phase 3 | 2018-01-06 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139 Huntington's Disease | Phase 2 | 2018-01-02 |
| Terminated | A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metas Urothelial Carcinoma | — | 2017-12-28 |
| Completed | A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Carcinoma, Non-small-cell Lung | — | 2017-12-27 |
| Completed | A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | 2017-12-27 |
| Completed | A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Dise Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | N/A | 2017-12-25 |
| Completed | A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epiderm Breast Neoplasms | Phase 1 / Phase 2 | 2017-12-22 |
| Terminated | A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanc Advanced BRAFV600 Wild-type Melanoma | Phase 3 | 2017-12-11 |
| Completed | A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) Urothelial Carcinoma, Carcinoma, Non-Small Cell Lung, Small Cell Lung Carcinoma | — | 2017-11-29 |
| Completed | A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Solid Tumors | Phase 1 | 2017-11-27 |
| Completed | A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tum Solid Tumors | Phase 2 | 2017-11-23 |
| Completed | A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps Nasal Polyps, Chronic Rhinosinusitis | Phase 3 | 2017-11-21 |
| Active Not Recruiting | A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, Diffuse Large B-Cell Lymphoma | Phase 3 | 2017-11-16 |
| Completed | A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps Nasal Polyps, Chronic Rhinosinusitis | Phase 3 | 2017-11-15 |
| Completed | Evaluate the Effect of Entrectinib on the Pharmacokinetics of Midazolam in Cancer Patients Advanced Solid Tumor | Phase 1 | 2017-11-14 |
| Completed | A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezol Multiple Myeloma | Phase 1 / Phase 2 | 2017-11-13 |
| Completed | Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic N Non-Small Cell Lung Cancer | — | 2017-11-09 |
| Terminated | A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 An Advanced Ovarian Cancer, Triple Negative Breast Cancer | Phase 1 | 2017-11-08 |
| Completed | A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent (NTD) Beta-Thalassemia Beta-Thalassemia | Phase 2 | 2017-10-26 |
| Completed | An Extension Study to Evaluate Long-Term Safety of Subcutaneous (SC) Tocilizumab in Participants With Giant Ce Giant Cell Arteritis | Phase 3 | 2017-10-25 |
| Completed | A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Partici Carcinoma, Non-Small-Cell Lung | Phase 4 | 2017-10-25 |
| Completed | Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis | Phase 3 | 2017-10-23 |
| Completed | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma | Phase 1 / Phase 2 | 2017-10-13 |
| Completed | A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of I Glaucoma, Open-angle, Ocular Hypertension | Phase 1 | 2017-10-10 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2017-09-22 |
| Active Not Recruiting | A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezoliz Cancer | Phase 3 | 2017-09-20 |
| Completed | An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell | — | 2017-09-15 |
| Completed | A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Non-Small Cell Lung Cancer | Phase 3 | 2017-09-11 |
| Completed | A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhib Hemophilia A | Phase 3 | 2017-09-05 |
| Completed | Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina Chronic Lymphocytic Leukemia | — | 2017-08-31 |
| Completed | A Study to Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax Diffuse Large B-cell Lymphoma, High-Grade B-cell Lymphoma | Phase 1 | 2017-08-28 |
| Completed | A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Triple-Negative Breast Cancer | Phase 3 | 2017-08-25 |
| Completed | An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monothe Rheumatoid Arthritis | Phase 3 | 2017-08-02 |
| Completed | Relative Bioavailability of Gantenerumab Produced by G4 Process Versus G3 Process Following Subcutaneous (SC) Healthy Participants | Phase 1 | 2017-08-01 |
| Completed | A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Triple-negative Breast Cancer | Phase 3 | 2017-07-24 |
| Completed | A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib Healthy Volunteers | Phase 1 | 2017-07-18 |
| Completed | A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urin Urinary Tract Infections | Phase 1 | 2017-07-11 |
| Completed | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2017-07-10 |
| Completed | A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearrang Carcinoma, Non-Small-Cell Lung | Phase 2 | 2017-07-10 |
| Completed | Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenn Duchenne Muscular Dystrophy | Phase 2 / Phase 3 | 2017-07-06 |
| Active Not Recruiting | A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Neoplasms | Phase 3 | 2017-07-05 |
| Completed | A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Duct Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2017-07-05 |
| Completed | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednison Metastatic Prostate Cancer | Phase 3 | 2017-06-30 |
| Active Not Recruiting | A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Dis Parkinson's Disease | Phase 2 | 2017-06-27 |
| Completed | Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Multiple Myeloma | Phase 1 | 2017-06-26 |
| Completed | Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advance Breast Neoplasms | Phase 1 | 2017-06-20 |
| Completed | Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Malignant Melanoma | Phase 1 | 2017-06-20 |
| Terminated | A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refrac Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse | Phase 1 / Phase 2 | 2017-06-15 |
| Completed | A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants Gram-negative Bacterial Infections | Phase 1 | 2017-06-15 |
| Completed | A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease Lung Diseases, Interstitial | Phase 2 | 2017-05-15 |
| Completed | Compare Bioavailability of RO7239361 After Subcutaneous Injection Healthy | Phase 1 | 2017-05-09 |
| Completed | A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell | — | 2017-05-03 |
| Completed | A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple Gynecologic Neoplasms | Phase 1 | 2017-04-27 |
| Completed | Efficacy and Safety of Trastuzumab Emtansine in Chinese Participants With Human Epidermal Growth Factor Recept Breast Cancer | Phase 3 | 2017-04-24 |
| Completed | Quality of Life Study in Participants With IPF Under Pirfenidone Treatment Idiopathic Pulmonary Fibrosis | — | 2017-04-18 |
| Completed | A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carbo Cervical Cancer | — | 2017-04-06 |
| Completed | A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice Rheumatoid Arthritis | — | 2017-03-30 |
| Terminated | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mil Alzheimer's Disease | Phase 3 | 2017-03-29 |
| Terminated | Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remit Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2017-03-24 |
| Completed | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067 Healthy Volunteers | Phase 1 | 2017-03-22 |